Literature DB >> 17409117

grp (chk1) replication-checkpoint mutations and DNA damage trigger a Chk2-dependent block at the Drosophila midblastula transition.

Saeko Takada1, Seongae Kwak, Birgit S Koppetsch, William E Theurkauf.   

Abstract

The 13 syncytial cleavage divisions that initiate Drosophila embryogenesis are under maternal genetic control. The switch to zygotic regulation of development at the midblastula transition (MBT) follows mitosis 13, when the cleavage divisions terminate, transcription increases and the blastoderm cellularizes. Embryos mutant for grp, which encodes Checkpoint kinase 1 (Chk1), are DNA-replication-checkpoint defective and fail to cellularize, gastrulate or to initiate high-level zygotic transcription at the MBT. The mnk (also known as loki) gene encodes Checkpoint kinase 2 (Chk2), which functions in DNA-damage signal transduction. We show that mnk grp double-mutant embryos are replication-checkpoint defective but cellularize, gastrulate and activate high levels of zygotic gene expression. We also show that grp mutant embryos accumulate DNA double-strand breaks and that DNA-damaging agents induce a mnk-dependent block to cellularization and zygotic gene expression. We conclude that the DNA-replication checkpoint maintains genome integrity during the cleavage divisions, and that checkpoint mutations lead to DNA damage that induces a novel Chk2-dependent block at the MBT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409117     DOI: 10.1242/dev.02831

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  22 in total

1.  Coupling of zygotic transcription to mitotic control at the Drosophila mid-blastula transition.

Authors:  Xuemin Lu; Jennifer M Li; Olivier Elemento; Saeed Tavazoie; Eric F Wieschaus
Journal:  Development       Date:  2009-06       Impact factor: 6.868

2.  Proliferation of Double-Strand Break-Resistant Polyploid Cells Requires Drosophila FANCD2.

Authors:  Heidi S Bretscher; Donald T Fox
Journal:  Dev Cell       Date:  2016-06-06       Impact factor: 12.270

3.  Regulation of zygotic genome activation and DNA damage checkpoint acquisition at the mid-blastula transition.

Authors:  Maomao Zhang; Priyanka Kothari; Mary Mullins; Michael A Lampson
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  Rapid DNA Synthesis During Early Drosophila Embryogenesis Is Sensitive to Maternal Humpty Dumpty Protein Function.

Authors:  Shera Lesly; Jennifer L Bandura; Brian R Calvi
Journal:  Genetics       Date:  2017-09-23       Impact factor: 4.562

Review 5.  Safeguarding genetic information in Drosophila.

Authors:  Tin Tin Su
Journal:  Chromosoma       Date:  2011-09-17       Impact factor: 4.316

6.  An essential role for the RNA-binding protein Smaug during the Drosophila maternal-to-zygotic transition.

Authors:  Beatrice Benoit; Chun Hua He; Fan Zhang; Sarah M Votruba; Wael Tadros; J Timothy Westwood; Craig A Smibert; Howard D Lipshitz; William E Theurkauf
Journal:  Development       Date:  2009-03       Impact factor: 6.868

7.  no poles encodes a predicted E3 ubiquitin ligase required for early embryonic development of Drosophila.

Authors:  Julie A Merkle; Jamie L Rickmyre; Aprajita Garg; Erin B Loggins; Jeanne N Jodoin; Ethan Lee; Louisa P Wu; Laura A Lee
Journal:  Development       Date:  2009-02       Impact factor: 6.868

Review 8.  Genome Duplication: The Heartbeat of Developing Organisms.

Authors:  Melvin L DePamphilis
Journal:  Curr Top Dev Biol       Date:  2016-01-20       Impact factor: 4.897

9.  HorkaD, a chromosome instability-causing mutation in Drosophila, is a dominant-negative allele of Lodestar.

Authors:  Tamas Szalontai; Imre Gaspar; Istvan Belecz; Iren Kerekes; Miklos Erdelyi; Imre Boros; Janos Szabad
Journal:  Genetics       Date:  2008-12-01       Impact factor: 4.562

10.  The endo-siRNA pathway is essential for robust development of the Drosophila embryo.

Authors:  Elena M Lucchetta; Richard W Carthew; Rustem F Ismagilov
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.